Haiming Yu

909 total citations
48 papers, 661 citations indexed

About

Haiming Yu is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Haiming Yu has authored 48 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Molecular Biology and 10 papers in Surgery. Recurrent topics in Haiming Yu's work include Spine and Intervertebral Disc Pathology (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Bone health and osteoporosis research (5 papers). Haiming Yu is often cited by papers focused on Spine and Intervertebral Disc Pathology (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Bone health and osteoporosis research (5 papers). Haiming Yu collaborates with scholars based in China, Australia and United Kingdom. Haiming Yu's co-authors include Yizhong Li, Junlan Yang, Shunchang Jiao, Xiaoyu He, Jiandong Wang, Ying Li, Xuedong Yao, Wei Zhang, Ting Tang and Shu Lin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Haiming Yu

45 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haiming Yu China 16 214 166 123 115 111 48 661
Leyla Didem Kozacı Türkiye 17 193 0.9× 77 0.5× 72 0.6× 144 1.3× 139 1.3× 58 900
Zhuang Cui China 18 251 1.2× 101 0.6× 82 0.7× 84 0.7× 228 2.1× 40 841
Xin Pan China 16 411 1.9× 124 0.7× 101 0.8× 87 0.8× 97 0.9× 24 844
Te‐Yang Huang Taiwan 12 165 0.8× 94 0.6× 61 0.5× 60 0.5× 167 1.5× 29 628
Huaqiang Tao China 13 481 2.2× 98 0.6× 115 0.9× 114 1.0× 117 1.1× 35 875
Masaki Arioka Japan 18 441 2.1× 178 1.1× 69 0.6× 52 0.5× 149 1.3× 48 925
Jianying Pan China 14 431 2.0× 106 0.6× 149 1.2× 148 1.3× 127 1.1× 29 988
Xiaolong Liang China 14 409 1.9× 89 0.5× 85 0.7× 110 1.0× 99 0.9× 32 849
Yohei Yamamoto Japan 17 393 1.8× 273 1.6× 121 1.0× 158 1.4× 156 1.4× 67 986
Meng Fan China 16 497 2.3× 125 0.8× 228 1.9× 59 0.5× 176 1.6× 74 930

Countries citing papers authored by Haiming Yu

Since Specialization
Citations

This map shows the geographic impact of Haiming Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiming Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiming Yu more than expected).

Fields of papers citing papers by Haiming Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiming Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiming Yu. The network helps show where Haiming Yu may publish in the future.

Co-authorship network of co-authors of Haiming Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Haiming Yu. A scholar is included among the top collaborators of Haiming Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiming Yu. Haiming Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Haiming, et al.. (2025). Patterns of exhaust pollution from vehicles traveling on dual-lane coal mine roads. Process Safety and Environmental Protection. 199. 107300–107300.
3.
Yu, Haiming, et al.. (2024). Oral dehydroepiandrosterone supplementation enhances osteoporotic fracture healing in the OVX rats. Bone. 187. 117201–117201. 1 indexed citations
4.
Zhou, Ling, Hongjiao Zhang, Juanjuan Zhou, et al.. (2023). A comprehensive analysis of the expression, immune infiltration, prognosis and partial experimental validation of CHST family genes in gastric cancer. Translational Oncology. 40. 101843–101843. 2 indexed citations
5.
Yu, Haiming, et al.. (2023). Research landscape and trends of melanoma immunotherapy: A bibliometric analysis. Frontiers in Oncology. 12. 1024179–1024179. 5 indexed citations
6.
Yu, Haiming, et al.. (2023). Lumbar Sympathetic Trunk Injury: An Underestimated Complication of Oblique Lateral Interbody Fusion. Orthopaedic Surgery. 15(4). 1053–1059. 6 indexed citations
7.
He, Xiaoyu, Zhihua Liu, Shupeng Chen, et al.. (2023). Osteoporosis treatment using stem cell-derived exosomes: a systematic review and meta-analysis of preclinical studies. Stem Cell Research & Therapy. 14(1). 72–72. 22 indexed citations
8.
Liu, Zhihua, et al.. (2023). Polydopamine and CuS/CaCO3 nanocomposites coated titanium alloy screw as efficient antibacterial device. Vacuum. 214. 112208–112208. 9 indexed citations
9.
He, Xiaoyu, Zhihua Liu, Yizhong Li, et al.. (2023). Annulus Fibrosus Repair for Lumbar Disc Herniation: A Meta-Analysis of Clinical Outcomes From Controlled Studies. Global Spine Journal. 14(1). 306–321. 10 indexed citations
10.
Yu, Haiming, et al.. (2022). The joint action of unfolded protein response, circZc3h4, and circRNA Scar in procymidone‐induced testicular injury in adolescent mice. Environmental Toxicology. 37(11). 2605–2614. 9 indexed citations
11.
Wu, Yanhong, et al.. (2021). Protective Role of lncRNA TTN-AS1 in Sepsis-Induced Myocardial Injury Via miR-29a/E2F2 Axis. Cardiovascular Drugs and Therapy. 36(3). 399–412. 14 indexed citations
12.
13.
Li, Yizhong, et al.. (2018). Low Grip Strength is a Strong Risk Factor of Osteoporosis in Postmenopausal Women. Orthopaedic Surgery. 10(1). 17–22. 44 indexed citations
14.
Wang, Pei‐Wen, Yizhong Li, Haiming Yu, et al.. (2018). Influence of bone densitometry on the anti-osteoporosis treatment after fragility hip fracture. Aging Clinical and Experimental Research. 31(10). 1525–1529. 11 indexed citations
15.
Tang, Ting, et al.. (2018). LncRNA DLX6-AS1/miR-129-5p/DLK1 axis aggravates stemness of osteosarcoma through Wnt signaling. Biochemical and Biophysical Research Communications. 507(1-4). 260–266. 51 indexed citations
16.
Liang, Yingchun, Xiaojie Xu, Haiming Yu, et al.. (2016). Raddeanoside R13 inhibits breast cancer cell proliferation, invasion, and metastasis. Tumor Biology. 37(7). 9837–9847. 15 indexed citations
17.
Yu, Haiming, Junlan Yang, Ying Li, & Shunchang Jiao. (2015). [The expression of thymic stromal lymphopoietin in primary tumors of breast cancer is associated with prognosis].. PubMed. 31(2). 239–43, 247. 2 indexed citations
18.
Yu, Haiming, Junlan Yang, Shunchang Jiao, et al.. (2015). Cytotoxic T lymphocyte antigen 4 expression in human breast cancer: implications for prognosis. Cancer Immunology Immunotherapy. 64(7). 853–860. 86 indexed citations
19.
Yu, Haiming, Junlan Yang, Shunchang Jiao, Jiandong Wang, & Ying Li. (2014). TGF-β1 precursor and CD8 are potential prognostic and predictive markers in operated breast cancer. Journal of Huazhong University of Science and Technology [Medical Sciences]. 34(1). 51–58. 9 indexed citations
20.
MacNeil, Adam J., Shunchang Jiao, Yong Yang, et al.. (2013). MAPK Kinase 3 Is a Tumor Suppressor with Reduced Copy Number in Breast Cancer. Cancer Research. 74(1). 162–172. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026